文献速递临床生化临床血液与体液质量管理与危急值

四种阳离子交换HPLC仪器测定糖化血红蛋白A1c的性能评估

Evaluation of four cation exchange HPLC instruments for the determination of hemoglobin A1c: the devil is in the detail.
PubMed 文献 · Clin Chem Lab Med · 2026-05-27

本研究采用CLSI评价方案评估4种阳离子交换HPLC仪器(Medconn MQ-3000、Lifotronic H100Plus、Mindray H-120、ARKRAY ADAMS A1c × HA-8110)测定HbA1c的精密度、准确度、线性、携带污染及干扰。结果显示所有仪器精密度CV在SI单位<1.2%、NGSP单位<0.6%,均符合IFCC和NGSP认证标准,但仅ARKRAY ADAMS A1c X HA-8110两种模式对调查的干扰物无干扰。

要点

  • 所有仪器精密度和标准化符合可接受标准。
  • 仅ARKRAY ADAMS A1c X HA-8110两种模式无干扰。
  • MQ-3000、H100Plus和H-120对至少一种参数有干扰。

核心结论

  • 所有4种仪器在精密度和标准化方面均符合既定接受标准。
  • 仅ARKRAY ADAMS A1c X HA-8110两种模式对调查的干扰物无干扰。
  • MQ-3000、H100Plus和H-120对至少一种评估参数存在干扰,且软件和用户手册需进一步完善。

研究设计与样本

  • 采用CLSI评价方案评估精密度(EP-5-A3)、准确度(EP-9-A3)、线性(EP-6)、携带污染(EP-10)及血红蛋白变异体等干扰。
  • 评估4种阳离子交换HPLC仪器:Medconn MQ-3000(常规模式)、Lifotronic H100Plus(变异模式)、Mindray H-120(标准模式和变异模式)、ARKRAY ADAMS A1c × HA-8110(快速模式和标准模式)。

主要发现

  • 患者样本浓度43 mmol/mol(6.1%)和83 mmol/mol(9.7%)时,各仪器CV在SI单位<1.2%、NGSP单位<0.6%。
  • 所有仪器符合IFCC认证标准。
  • 除H100Plus与Premier Hb9210和Roche Tina-quant Hemoglobon A1c Gen.3 on cobas c 513比较、H-120标准模式与Sebia CAPILLARYS 3 Octa方法比较外,所有仪器以至少5/7 Certified SRMP符合NGSP认证标准。
  • 仅ARKRAY ADAMS A1c X HA-8110两种模式对调查的干扰物无干扰。

关键数值与推荐

  • 精密度:患者样本浓度43 mmol/mol(6.1%)和83 mmol/mol(9.7%)时CV<1.2%(SI单位)或<0.6%(NGSP单位)。
  • NGSP认证:至少5/7 Certified SRMP符合,例外为H100Plus与Premier Hb9210和Roche Tina-quant Hemoglobon A1c Gen.3 on cobas c 513比较、H-120标准模式与Sebia CAPILLARYS 3 Octa方法比较。

临床怎么用

  • 选择HbA1c检测仪器时需考虑其对血红蛋白变异体等干扰物的干扰情况。
  • ARKRAY ADAMS A1c X HA-8110两种模式未显示对调查干扰物的干扰。
  • 使用MQ-3000、H100Plus和H-120时需注意其至少对一种评估参数存在干扰。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim of this study was to evaluate 4 cation exchange HPLC instruments namely, the Medconn MQ-3000 in Normal Mode (NM), Lifotronic H100Plus in Variant Mode (VM), Mindray H-120 in Standard Mode (SM) and VM and the ARKRAY ADAMS A1c × HA-8110 in Quick Mode (QM) and SM for the measurement of HbA1c. METHODS: Certified Clinical and Laboratory Standards Institute (CLSI) Evaluation Protocols were employed to assess precision (EP-5-A3), accuracy (EP-9-A3), linearity (EP-6), carryover (EP-10), as well as the interference of hemoglobin variants and other potential analytical interferences. RESULTS: With patient samples at concentrations of 43 mmol/mol (6.1 %) and 83 mmol/mol (9.7 %) each instrument CV was <1.2 % in SI units (<0.6 % in NGSP units). All instruments met the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) certification criteria, and all instruments met National Glycohemoglobin Standardization Program (NGSP) certification criteria with at least 5/7 Certified Secondary Reference Measurement Procedures (SRMP), except for the H100Plus compared to Premier Hb9210 and Roche Tina-quant Hemoglobon A1c Gen.3 on cobas c 513, and for the H-120 SM compared to the Sebia CAPILLARYS 3 Octa method. Only the ARKRAY ADAMS A1c X HA-8110 in both modes showed no interference of any from the investigated interferents. CONCLUSIONS: The analytical performance of all 4 instruments, with respect to precision and standardization, met the established acceptance criteria. Nevertheless, the MQ-3000, H100Plus, and H-120 each exhibited interference with at least one of the evaluated parameters. In addition for these three instruments, further refinement of the software and accompanying user manual remains warranted.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Lenters-Westra E, Siebelder C, English E, et al. Evaluation of four cation exchange HPLC instruments for the determination of hemoglobin A1c: the devil is in the detail. Clin Chem Lab Med. 2026. PMID: 42200582. doi:10.1515/cclm-2026-0483

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。